No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PROF Profound Medical
- 7.415
- +0.055+0.75%
Close May 6 16:00 ET
- 7.360
- -0.055-0.74%
Post 19:39 ET
181.14MMarket Cap-5492P/E (TTM)
7.805High7.350Low13.89KVolume7.510Open7.360Pre Close104.54KTurnover0.06%Turnover RatioLossP/E (Static)24.43MShares15.49052wk High5.81P/B164.70MFloat Cap7.11052wk Low--Dividend TTM22.21MShs Float28.970Historical High--Div YieldTTM6.18%Amplitude3.100Historical Low7.523Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Profound Medical's TULSA Gains Global Recognition
Profound Medical Brief: Says "Growing Body of Clinical Evidence" Points to Potential of Its TULSA Procedure "Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum"
04:16 PM EDT, 05/06/2024 (MT Newswires) -- Profound Medical Brief: Says "Growing Body of Clinical Evidence" Points to Potential of Its TULSA Procedure "Becoming a Mainstream Treatment Modality Across
Profound Medical Unveils Q1 2024 Financials
Profound Medical to Release First Quarter 2024 Financial Results on May 9 - Conference Call to Follow
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Shareholders in Profound Medical (TSE:PRN) Are in the Red If They Invested Three Years Ago
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg